The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.
Open accessAbstract
Although previous studies using human cytokines in rabbits and rats have provided evidence of the participation of tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) in the meningeal inflammatory cascade, the results obtained by several groups of investigators have been discordant or, at times, contradictory. In the present study, homologous cytokines were applied to the rabbit meningitis model. Intracisternal administration of 10(2)-10(5) IU of purified rabbit TNF-alpha (RaTNF-alpha) produced significant cerebrospinal fluid (CSF) inflammation. A similar response was observed after intracisternal inoculation of 5-200 ng of rabbit recombinant IL-1 beta (rrIL-1 beta). Preincubation of these two mediators with their specific antibodies resulted in an almost complete suppression of the CSF inflammatory response. In animals with Haemophilus influenzae type b lipooligosaccharide-induced meningitis, intracisternal administration of anti-rrIL-1 beta, anti-RaTNF-alpha, or both resulted in a significant modulation of meningeal inflammation. Simultaneous administration of 10(3) IU of RaTNF-alpha and 5 ng of rrIL-1 beta resulted in a synergistic inflammatory response manifested by a more rapid and significantly increased influx of white blood cells into the CSF compared with results after each cytokine given alone. These data provide evidence for a seminal role of TNF-alpha and IL-1 beta in the initial events of meningeal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels
Tsai, C.-M., & Frasch, C. E. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90673-x · Cited by 3,067
Dinarello, C. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.1.51 · Cited by 1,644
Dinarello, C. A. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277884 · Cited by 1,532
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Cachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,432
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
Flick, D. A., & Gifford, G. E. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90147-9 · Cited by 745
Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells
Frei, K., Siepl, C., Groscurth, P., Bodmer, S., Schwerdel, C., & Fontana, A. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170909 · Cited by 642
Fong, Y., Tracey, K. J., Moldawer, L. L., Hesse, D. G., Manogue, K. B., Kenney, J. S., Lee, A. T., Kuo, G. C., Allison, A. C., & Lowry, S. F. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1627 · Cited by 641
Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, P., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.1859 · Cited by 454
Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.
Robbins, D. S., Shirazi, Y., Drysdale, B. E., Lieberman, A., Shin, H. S., & Shin, M. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.8.2593 · Cited by 429
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.
Fontana, A., Hengartner, H., de Tribolet, N., & Weber, E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.4.1837 · Cited by 366
Saukkonen, K., Sande, S., Cioffe, C., Wolpe, S., Sherry, B., Cerami, A., & Tuomanen, E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.439 · Cited by 361
The Induction of Meningeal Inflammation by Components of the Pneumococcal Cell Wall
Tuomanen, E., Liu, H., Hengstler, B., Zak, O., & Tomasz, A. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.5.859 · Cited by 355
Interleukin 1: the first interleukin
di Giovine, F. S., & Duff, G. W. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90005-t · Cited by 338
Dacey, R. G., & Sande, M. A. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.4.437 · Cited by 287
Mustafa, M. M., Lebel, M. H., Ramilo, O., Olsen, K. D., Reisch, J. S., Beutler, B., & McCracken, G. H. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80067-8 · Cited by 276
Self-citationBEUTLER, B., & CERAMI, A. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-57 · Cited by 251
Leist, T. P., Frei, K., Kam-Hansen, S., Zinkernagel, R. M., & Fontana, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1743 · Cited by 244
Tuomanen, E., Tomasz, A., Hengstler, B., & Zak, O. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.535 · Cited by 232
Cybulsky, M. I., Chan, M. K. W., & Movat, H. Z. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_6 · Cited by 229
Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications
Sáez-Llorens, X., Ramilo, O., Mustafa, M. M., Mertsold, J., & McCracken, G. H. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82647-2 · Cited by 220
Self-citationWispelwey, B., Lesse, A. J., Hansen, E. J., & Scheld, W. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113736 · Cited by 192
Self-citationRanges, G. E., Zlotnik, A., Espevik, T., Dinarello, C. A., Cerami, A., & Palladino, M. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1472 · Cited by 158
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis.
Mustafa, M. M., Ramilo, O., Olsen, K. D., Franklin, P., Hansen, E. J., Beutler, B., & McCracken, G. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114292 · Cited by 141
Self-citationMcCracken, G. H., Mustafa, M. M., Ramilo, O., Olsen, K. D., & Risser, R. C. (1989) · PubMed · Cited by 84
Self-citationWispelwey, B., Hansen, E. J., & Scheld, W. M. (1989) · Infection and Immunity · doi:10.1128/iai.57.8.2559-2562.1989 · Cited by 83
Self-citationBiological and biochemical characterization of an interleukin 1‐like factor from rat C6 glioma cells
Fontana, A., McAdam, K. P. W. J., Kristensen, F., et al. (1983) · European Journal of Immunology · doi:10.1002/eji.1830130814 · Cited by 75
Tumour necrosis factor-alpha in infectious meningitis.
Nadal, D., Leppert, D., Frei, K., Gallo, P., Lamche, H. R., & Fontana, A. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.9.1274 · Cited by 72
Cited by
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects
Rock, R. B., Olin, M., Baker, C. A., Molitor, T. W., & Peterson, P. K. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-07 · Cited by 763
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Metadata
- Authors
- Ramilo, O., Sáez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K. D., Hansen, E. J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., & McCracken, G. H.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1990-08-01
- Volume
- 172
- Issue
- 2
- Pages
- 497-507
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2162456014
- Cited by
- 294
- References
- 28
- FWCI
- 20.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.